Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-21-005491

Director sold 15,635 shares at $15.75 ($246,328)

  • Director acquired 15,635 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Egros Fabrice · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-18 Exercise or conversion : show line 1 in the form +15,635 $7.88 $123,204 31,635 D
2021-08-18 Sale : show line 2 in the form −15,635 $15.75 $246,328 16,000 D
Open-market sales · 15,635 sh · avg $15.75 · $246,328

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-18 Exercise or conversion : show line 3 in the form Stock Options (Right to buy) −15,635 0 D
Loading xslF345X03/primarydocument.xml…